アクセス数 : ?
ダウンロード数 : ?
ID 114064
著者
Iwayama, Yoshimi RIKEN Brain Science Institute
Toyota, Tomoko RIKEN Brain Science Institute
Ikeda, Masashi Fujita Health University
Yamamori, Hidenaga Osaka University
Shimodera, Shinji Kochi University
Hashimoto, Ryota Osaka University
Iwata, Nakao Fujita Health University
Yoshikawa, Takeo RIKEN Brain Science Institute
資料タイプ
学術雑誌論文
抄録
Background: Alterations in one-carbon metabolism have been associated with schizophrenia, and vitamin B6 is one of the key components in this pathway. Methods: We first conducted a case–control study of serum pyridoxal levels and schizophrenia in a large Japanese cohort (n = 1276). Subsequently, we conducted a meta-analysis of association studies (n = 2125). Second, we investigated whether rs4654748, which was identified in a genome-wide association study as a vitamin B6-related single nucleotide polymorphism, was genetically implicated in patients with schizophrenia in the Japanese population (n = 10 689). Finally, we assessed the effect of serum pyridoxal levels on schizophrenia risk using a Mendelian randomization (MR) approach. Results: Serum pyridoxal levels were significantly lower in patients with schizophrenia than in controls, not only in our cohort, but also in the pooled data set of the meta-analysis of association studies (standardized mean difference –0.48, 95% confidence interval [CI] –0.57 to –0.39, p = 9.8 × 10–24). We failed to find a significant association between rs4654748 and schizophrenia. Furthermore, an MR analysis failed to find a causal relationship between pyridoxal levels and schizophrenia risk (odds ratio 0.99, 95% CI 0.65–1.51, p = 0.96). Limitations: Food consumption and medications may have affected serum pyridoxal levels in our cross-sectional study. Sample size, number of instrumental variables and substantial heterogeneity among patients with schizophrenia are limitations of an MR analysis. Conclusion: We found decreased serum pyridoxal levels in patients with schizophrenia in this observational study. However, we failed to obtain data supporting a causal relationship between pyridoxal levels and schizophrenia risk using the MR approach.
掲載誌名
Journal of Psychiatry & Neuroscience
ISSN
11804882
cat書誌ID
AA10850062
出版者
Joule
43
3
開始ページ
194
終了ページ
200
発行日
2018-02-06
権利情報
Open Access Journal
EDB ID
出版社版DOI
出版社版URL
フルテキストファイル
言語
eng
著者版フラグ
出版社版
部局
病院
医学系